Metabolic and chemical origins of cross-reactive immunological reactions to arylamine benzenesulfonamides: T-cell responses to hydroxylamine and nitroso derivatives

Chemical Research in Toxicology

Volumn 23, Issue 1, 2010, Pages 184-192

  Castrejon, J Luis ^a   Lavergne, Sidonie N ^a   El Sheikh, Ayman ^a   Farrell, John ^a   Maggs, James L ^a   Sabbani, Sunil ^a   O'Neill, Paul M ^a   Kevin Park, B ^a   Naisbitt, Dean J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINE; BENZENESULFONAMIDE DERIVATIVE; GLUTATHIONE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYLAMINE; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; NITROSO DERIVATIVE; SULFADIAZINE; SULFAMETHOXAZOLE; SULFAPYRIDINE;

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; AQUEOUS SOLUTION; ARTICLE; BAGG ALBINO MOUSE; CELL ACTIVATION; CELL ISOLATION; CROSS REACTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HYPERSENSITIVITY; IMMUNITY; LYMPHOCYTE ACTIVATION; METABOLITE; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN BINDING; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTI-INFECTIVE AGENTS; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYDROXYLAMINE; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NITROSO COMPOUNDS; SULFAMETHOXAZOLE; SULFANILAMIDES; T-LYMPHOCYTES;

MUS;

EID: 75149137515     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx900329b     Document Type: Article

References (66)

1. Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., Farrar, K., Park, B. K., and Breckenridge, A. M. (2004) Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ 329, 15-19.
2. Pirmohamed, M., and Park, B. K. (2001) Genetic susceptibility to adverse drug reactions. Trends Pharmacol. Sci. 22, 298-305.
3. Park, K., Williams, D. P., Naisbitt, D. J., Kitteringham, N. R., and Pirmohamed, M. (2005) Investigation of toxic metabolites during drug development. Toxicol. Appl. Pharmacol. 207, 425-434.
4. Smith, D. A., Obach, R. S., Williams, D. P., and Park, B. K. (2009) Clearing the MIST (metabolites in safety testing) of time: The impact of duration of administration on drug metabolite toxicity. Chem.-Biol. Interact. 179, 60-67.
5. Pichler, W. J. (2003) Delayed drug hypersensitivity reactions. Ann. Intern. Med. 139, 683-693.
6. Lavergne, S. N., Park, B. K., and Naisbitt, D. J. (2008) The roles of drug metabolism in the pathogenesis of T-cell-mediated drug hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 8, 299-307.
7. Wu, Y., Farrell, J., Pirmohamed, M., Park, B. K., and Naisbitt, D. J. (2007) Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity. J. Allergy Clin. Immunol. 119, 973-981.
8. Beeler, A., Engler, O., Gerber, B. O., and Pichler, W. J. (2006) Longlasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J. Allergy Clin. Immunol. 117, 455-462.
9. Nassif, A., Bensussan, A., Boumsell, L., Deniaud, A., Moslehi, H., Wolkenstein, P., Bagot, M., and Roujeau, J. C. (2004) Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J. Allergy Clin. Immunol. 114, 1209-1215.
10. Masters, P. A., O'Bryan, T. A., Zurlo, J., Miller, D. Q., and Joshi, N. (2003) Trimethoprim-sulfamethoxazole revisited. Arch. Intern. Med. 163, 402-410.
11. Cribb, A. E., and Spielberg, S. P. (1990) An in vitro investigation of predisposition to sulphonamide idiosyncratic toxicity in dogs. Vet. Res. Commun. 14, 241-252.
12. Gill, H. J., Hough, S. J., Naisbitt, D. J., Maggs, J. L., Kitteringham, N. R., Pirmohamed, M., and Park, B. K. (1997) The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat. J. Pharmacol. Exp. Ther. 282, 795-801.
13. Roychowdhury, S., Vyas, P. M., Reilly, T. P., Gaspari, A. A., and Svensson, C. K. (2005) Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes. J. Pharmacol. Exp. Ther. 314, 43-52.
14. Sanderson, J. P., Naisbitt, D. J., Farrell, J., Ashby, C. A., Tucker, M. J., Rieder, M. J., Pirmohamed, M., Clarke, S. E., and Park, B. K. (2007) Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling. J. Immunol. 178, 5533-5542.
15. Naisbitt, D. J., O'Neill, P. M., Pirmohamed, M., and Park, B. K. (1996) Synthesis and reactions of nitroso sulfamethoxazole with biological nucleophiles - Implications for immune-mediated toxicity. Bioorg. Med. Chem. Lett. 6, 1511-1516.
16. Cribb, A. E., Miller, M., Leeder, J. S., Hill, J., and Spielberg, S. P. (1991) Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity. Drug Metab. Dispos. 19, 900-906.
17. Naisbitt, D. J., Hough, S. J., Gill, H. J., Pirmohamed, M., Kitteringham, N. R., and Park, B. K. (1999) Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity. Br. J. Pharmacol. 126, 1393-1407.
18. Trepanier, L. A., Yoder, A. R., Bajad, S., Beckwith, M. D., Bellehumeur, J. L., and Graziano, F. M. (2004) Plasma ascorbate deficiency is associated with impaired reduction of sulfamethoxazolenitroso in HIV infection. JAIDS, J. Acquired Immune Defic. Syndr. 36, 1041-1050.
19. Naisbitt, D. J., Farrell, J., Gordon, S. F., Maggs, J. L., Burkhart, C., Pichler, W. J., Pirmohamed, M., and Park, B. K. (2002) Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation. Mol. Pharmacol. 62, 628-637.
20. Cheng, L., Stewart, B. J., You, Q., Petersen, D. R., Ware, J. A., Piccotti, J. R., Kawabata, T. T., and Ju, C. (2008) Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo. Mol. Pharmacol. 73, 1769-1775.
21. Meekins, C. V., Sullivan, T. J., and Gruchalla, R. S. (1994) Immunochemical analysis of sulfonamide drug allergy: Identification of sulfamethoxazole-substituted human serum proteins. J. Allergy Clin. Immunol. 94, 1017-1024.
22. Gruchalla, R. S., Pesenko, R. D., Do, T. T., and Skiest, D. J. (1998) Sulfonamide-induced reactions in desensitized patients with AIDSsThe role of covalent protein haptenation by sulfamethoxazole. J. Allergy Clin. Immunol. 101, 371-378.
23. Callan, H. E., Jenkins, R. E., Maggs, J. L., Lavergne, S. N., Clarke, S. E., Naisbitt, D. J., and Park, B. K. (2009) Multiple adduction reactions of nitroso sulfamethoxazole with cysteinyl residues of peptides and proteins: Implications for hapten formation. Chem. Res. Toxicol. 22, 937-948.
24. Cribb, A. E., Nuss, C. E., Alberts, D. W., Lamphere, D. B., Grant, D. M., Grossman, S. J., and Spielberg, S. P. (1996) Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection. Chem. Res. Toxicol. 9, 500-507.
25. Naisbitt, D. J., Gordon, S. F., Pirmohamed, M., Burkhart, C., Cribb, A. E., Pichler, W. J., and Park, B. K. (2001) Antigenicity and immunogenicity of sulphamethoxazole: Demonstration of metabolismdependent haptenation and T-cell proliferation in vivo. Br. J. Pharmacol. 133, 295-305.
26. Manchanda, T., Hess, D., Dale, L., Ferguson, S. G., and Rieder, M. J. (2002) Haptenation of sulfonamide reactive metabolites to cellular proteins. Mol. Pharmacol. 62, 1011-1026.
27. Farrell, J., Naisbitt, D. J., Drummond, N. S., Depta, J. P., Vilar, F. J., Pirmohamed, M., and Park, B. K. (2003) Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans. J. Pharmacol. Exp. Ther. 306, 229-237.
28. Choquet-Kastylevsky, G., Santolaria, N., Tedone, R., Aujoulat, M., and Descotes, J. (2001) Induction of delayed-type hypersensitivity to sulfamethoxazole in mice: Role of metabolites. Toxicol. Lett. 119, 183-192.
29. Burkhart, C., von Greyerz, S., Depta, J. P., Naisbitt, D. J., Britschgi, M., Park, K. B., and Pichler, W. J. (2001) Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole- metabolite-specific human CD4+ T-cells. Br. J. Pharmacol. 132, 623-630.
30. Schnyder, B., Burkhart, C., Schnyder-Frutig, K., von Greyerz, S., Naisbitt, D. J., Pirmohamed, M., Park, B. K., and Pichler, W. J. (2000) Recognition of sulfamethoxazole and its reactive metabolites by drugspecific CD4+ T cells from allergic individuals. J. Immunol. 164, 6647-6654.
31. Chamberlin, K. W., and Silverman, A. R. (2009) Celecoxib-associated anaphylaxis. Ann. Pharmacother. 43, 777-781.
32. Depta, J. P., Altznauer, F., Gamerdinger, K., Burkhart, C., Weltzien, H. U., and Pichler, W. J. (2004) Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity. J. Allergy Clin. Immunol. 113, 519-527.
33. Dibbern, D. A., Jr., and Montanaro, A. (2008) Allergies to sulfonamide antibiotics and sulfur-containing drugs. Ann. Allergy Asthma Immunol. 100, 91-100; quiz 100-103, 111.
34. Smith, D. A., and Jones, R. M. (2008) The sulfonamide group as a structural alert: A distorted story? Curr. Opin. Drug Discovery Dev. 11, 72-79.
35. Smith, W. B., and Mullins, R. J. (2007) No proof of cross-reactivity between celecoxib and antibiotic sulfonamides. Intern. Med. J. 37, 347-348.
36. von Greyerz, S., Bultemann, G., Schnyder, K., Burkhart, C., Lotti, B., Hari, Y., and Pichler, W. J. (2001) Degeneracy and additional alloreactivity of drug-specific human alpha beta(+) T cell clones. Int. Immunol. 13, 877-885.
37. von Greyerz, S., Zanni, M. P., Frutig, K., Schnyder, B., Burkhart, C., and Pichler, W. J. (1999) Interaction of sulfonamide derivatives with the TCR of sulfamethoxazole-specific human alpha beta+ T cell clones. J. Immunol. 162, 595-602.
38. Schmid, D. A., Depta, J. P., Luthi, M., and Pichler, W. J. (2006) Transfection of drug-specific T-cell receptors into hybridoma cells: Tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds. Mol. Pharmacol. 70, 356-365.
39. Ayyangar, N. R., Lugade, A. G., Nikrad, P. V., and Sharma, V. K. (1981) Catalytic reduction of nitroarenes with hydrazine hydrate in suitable solvents. Synthesis 640.
40. Johnstone, R. A. W., Wilby, A. H., and Entwistle, I. D. (1985) Heterogeneous catalytic transfer hydrogenation and its relation to other methods for reduction of organic compounds. Chem. Rev. 85, 129-170.
41. Ayyangar, N. R., Brahme, K. C., Kalkote, U. R., and Srinivasan, K. V. (1984) Facile transfer-reduction of nitroarenes to N-arylhydroxylamines with hydrazine in the presence of Raney-nickel. Synthesis 938-941.
42. Entwistle, I. D., Gilkerson, T., Johnstone, R. A. W., and Telford, R. P. (1978) Rapid catalytic transfer reduction of aromatic nitro compounds to hydroxylamines. Tetrahedron 34, 213-215.
43. Entwistle, I. D., Jackson, A. E., Johnstone, R. A. W., and Telford, R. P. (1977) Reduction of nitro-compounds. J. Chem. Soc., Perkin Trans. 1, 443-444.
44. Naisbitt, D. J., O'Neill, P. M., Pirmohamed, M., and Park, K. B. (1996) Synthesis and reactions of nitroso sulphamethoxazole with biological nucleophiles: Implications for immune mediated toxicity. Bioorg. Med. Chem. Lett. 6, 1511-1516.
45. Gowenlock, B. G., and Richter-Addo, G. B. (2004) Preparations of C-nitroso compounds. Chem. Rev. 104, 3315-3340.
46. Mauri-Hellweg, D., Bettens, F., Mauri, D., Brander, C., Hunziker, T., and Pichler, W. J. (1995) Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J. Immunol. 155, 462-472.
47. Schaerli, P., Britschgi, M., Keller, M., Steiner, U. C., Steinmann, L. S., Moser, B., and Pichler, W. J. (2004) Characterization of human T cells that regulate neutrophilic skin inflammation. J. Immunol. 173, 2151-2158.
48. Wu, Y., Sanderson, J. P., Farrell, J., Drummond, N. S., Hanson, A., Bowkett, E., Berry, N., Stachulski, A. V., Clarke, S. E., Pichler, W. J., Pirmohamed, M., Park, B. K., and Naisbitt, D. J. (2006) Activation of T cells by carbamazepine and carbamazepine metabolites. J. Allergy Clin. Immunol. 118, 233-241.
49. Landsteiner, K., and Jacobs, J. (1935) Studies on the sensitization of animals with simple chemical compounds. J. Exp. Med. 61, 643-656.
50. Park, B. K., Pirmohamed, M., and Kitteringham, N. R. (1998) Role of drug disposition in drug hypersensitivity: A chemical, molecular and clinical perspective. Chem. Res. Toxicol. 9, 969-988.
51. Summan, M., and Cribb, A. E. (2002) Novel non-labile covalent binding of sulfamethoxazole reactive metabolites to cultured human lymphoid cells. Chem.-Biol. Interact. 142, 155-173.
52. Engler, O. B., Strasser, I., Naisbitt, D. J., Cerny, A., and Pichler, W. J. (2004) A chemically inert drug can stimulate T cells in vitro by their T cell receptor in non-sensitised individuals. Toxicology 197, 47-56.
53. McLeod, R., Khan, A. R., Noble, G. A., Latkany, P., Jalbrzikowski, J., and Boyer, K. (2006) Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis. Pediatr. Infect. Dis. J. 25, 270-272.
54. Winter, H. R., and Unadkat, J. D. (2005) Identification of cytochrome P450 and arylamine N-acetyltransferase isoforms involved in sulfadiazine metabolism. Drug Metab. Dispos. 33, 969-976.
55. Pirmohamed, M., Coleman, M. D., Hussain, F., Breckenridge, A. M., and Park, B. K. (1991) Direct and metabolism-dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes. Br. J. Clin. Pharmacol. 32, 303-310.
56. Reilly, T. P., Bellevue, F. H., 3rd, Woster, P. M., and Svensson, C. K. (1998) Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone. Biochem. Pharmacol. 55, 803-810.
57. Pirmohamed, M., Coleman, M. D., Hussain, F., Breckenridge, A. M., and Park, B. K. (1991) Direct and metabolism-dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes. Br. J. Clin. Pharmacol. 32, 303-310.
58. Rieder, M. J., Uetrecht, J., Shear, N. H., and Spielberg, S. P. (1988) Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides. J. Pharmacol. Exp. Ther. 244, 724-728.
59. Lavergne, S. N., Kurian, J. R., Bajad, S. U., Maki, J. E., Yoder, A. R., Guzinski, M. V., Graziano, F. M., and Trepanier, L. A. (2006) Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso. Toxicology 222, 25-36.
60. Mitra, A. K., Thummel, K. E., Kalhorn, T. F., Kharasch, E. D., Unadkat, J. D., and Slattery, J. T. (1996) Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers. Clin. Pharmacol. Ther. 59, 332-340.
61. Gill, H. J., Maggs, J. L., Madden, S., Pirmohamed, M., and Park, B. K. (1996) The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazole. Br. J. Clin. Pharmacol. 42, 347-353.
62. Dearman, R. J., Warbrick, E. V., Skinner, R., and Kimber, I. (2002) Cytokine fingerprinting of chemical allergens: Species comparisons and statistical analyses. Food Chem. Toxicol. 40, 1881-1892.
63. Dearman, R. J., Moussavi, A., Kemeny, D. M., and Kimber, I. (1996) Contribution of CD4+ and CD8+ T lymphocyte subsets to the cytokine secretion patterns induced in mice during sensitization to contact and respiratory chemical allergens. Immunology 89, 502-510.
64. von Stebut, E., and Udey, M. C. (2004) Requirements for Th1-dependent immunity against infection with Leishmania major. Microbes Infect. 6, 1102-1109.
65. Hopkins, J. E., Naisbitt, D. J., Humphreys, N., Dearman, R. J., Kimber, I., and Park, B. K. (2005) Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells. Toxicology 206, 221-231.
66. Lochmatter, P., Beeler, A., Kawabata, T. T., Gerber, B. O., and Pichler, W. J. (2009) Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-gamma in patients with delayed-type drug hypersensitivity. Allergy 64, 1269-1278.